Cassidy K, Gueorguieva I, Miles C, Rehmel J, Yi P, and Ehlhardt W. (2017). Disposition and metabolism of [14C]-galunisertib, a TGF-bRI kinase/ALK5 inhibitor, following oral administration in healthy subjects and mechanistic prediction of the effect of itraconazole on galunisertib pharmacokinetics. Xenobiotica. http://dx.doi.org/10.1080/00498254.2017.1323137.
When the above article was first published online, and were incorrect.
The correct figures are shown here: